SYSTEMIC SUSTAINED RELEASE DELIVERY OF ANTIRETROVIRAL AGENTS FOR HIV PREVENTION
Grant Source:
NIH/NIAID: 5R01AI120748-02; Marc Michael Baum (PI); 06/26/15 - 05/31/20
Health Topics:
NIH/NIAID
Development of Ultra Long-Acting Oral HIV Therapies
Grant Source:
NIH/NIAID: 1R01AI131416-01; Andrew Martin Bellinger (PI); 03/22/17 - 02/28/22
Health Topics:
PREVENTION OF HIV ACQUISITION BY LONG-ACTING ANTIRETROVIRAL PREP
Grant Source:
NIH/NIAID: 4R01AI073146-09; Victor J. Garcia-Martinez (PI); 01/05/02 - 07/31/17
Health Topics:
Long-Acting Antiretroviral Nanoparticles for HIV Prophylaxis
Grant Source:
NIH/NIAID: 5R01AI117740-03; Christopher J. Destache (PI); 02/04/16 - 01/31/18
Health Topics:
DEVELOPMENT AND PRE-CLINICAL EVALUATION OF A NOVEL POLYMER-BASED IN-SITU FORMING IMPLANT (ISFI) FOR LONG-ACTING HIV PREP
Grant Source:
NIH/NIAD; 1R01AI131430-01; Soumya Rahima Benhabbour (PI); 03/06/17 - 02/29/20
Health Topics:
Development of Ultra Long-Acting Oral HIV Therapies
Grant Source:
Non-adherence to anti-retroviral therapy by HIV+ patients results in increased viral loads and risk of emergence of drug-resistant HIV strains. This poses a major public health threat. Lyndra Co. has developed an orally available, long-acting drug delivery system that it will now formulate to deliver anti-retrovirals.
Health Topics:
PREVENTION OF HIV ACQUISITION BY LONG-ACTING ANTIRETROVIRAL PREP
Grant Source:
NIH/NIAID; 4R01AI073146-09: Victor J. Garcia-Martinez (PI); 05/01/07 - 07/31/17
Health Topics:
Sustained Long Acting Prevention Against HIV Program Operation
Grant Source:
NIH/NIAID; 5UM1AI120184-02; Thomas Hope (PI); 07/07/15 - 06/30/20
Health Topics:
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention
Grant Source:
NIH/NIAID 5R01AI120748-02; Marc M. Baum (PI); 06/26/15 - 05/31/20
Health Topics: